MiRNAs unter Vedolizumab bei Colitis ulcerosa

Prosenz, Julian (PI)
Messner, Zora (PI)

Division of Internal Medicine 2 (University Hospital St. Pölten)

Short title	MiCuVed
Status	Active
Effective start/end date	01.03.2024 → 28.02.2027

Funding

Forschungsimpulse